Professor Farzin Farzaneh

King’s College London
Professor of Molecular Medicine, Director of Cell and Gene Therapy

Farzin Farzaneh D.Phil., FRCPath., FRSB
Professor of Molecular Medicine, and Director of Cell and Gene Therapy – King’s.
Consultant in Specialist Medicine, King’s College Hospital

Farzin Farzaneh holds the Chair of Molecular Medicine at King’s College London. He has published over 250 research articles with an average citation of over 30, and an Impact Factor of 47. He has run a licensed GMP facility at King’s College London, since 2001, for the production of cell and gene therapy based investigational medicinal products. Farzin has extensive industrial and academic collaborations, including research council, charitable and pharmaceutical sponsorships of over £25M. He is appointed by the Commission on Human Medicines, as a member of the Clinical Trials, Biologicals & Vaccines Expert Advisory Group since 2016. He is the recipient of 2016 Distinguished Scientist Award of the US Society for Experimental Biology & Medicine.

dont miss

Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

Cell and gene based therapy of cancer is making major improvements to the treatment of cancer. The development of new strategies for the development of chimeric antigen receptor T cells, genetically modified cancer cell vaccines and therapeutic cancer vaccines for the specific induction of cellular immunity will be described.

EVEN MORE SEMINARS

  • Camilo Colaco: Speaking at the Oncology Convention

    Camilo Colaco
    ImmunoBiology

    The immunobiology of immunotherapy

  • Profess Liz Ward: Speaking at the Oncology Convention

    Profess Liz Ward
    Centre for Functioning and Health Research, Metro South Hospital and Health Service, and The Univers

    Laryngectomy rehabilitation: Opportunities for improving speech pathology supports via telehealth

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment

  • Professor David Maintz: Speaking at the Oncology Convention

    Professor David Maintz
    University Hospital Cologne, Department of Radiology

    Spectral CT: Dual layer technology helps to increase diagnostic confidence

  • Stéfan Halbherr: Speaking at the Oncology Convention

    Stéfan Halbherr
    InnoMedica

    Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration